Amicus Therapeutics Inc. buy Cantor Fitzgerald
Start price
29.02.24
/
50%
€11.80
Target price
28.02.25
€20.36
Performance (%)
-17.37%
Price
19.09.24
€9.75
Summary
This prediction is currently active. The price of Amicus Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -17.37%. This prediction currently runs until 28.02.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amicus Therapeutics Inc. | -3.465% | -3.465% |
iShares Core DAX® | 2.291% | 2.984% |
iShares Nasdaq 100 | 1.336% | -0.196% |
iShares Nikkei 225® | 1.132% | 2.488% |
iShares S&P 500 | 1.272% | 1.334% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $22.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat